A Phase II Study of Sitravatinib Combined With Tislelizumab Plus Docetaxel for Acquired Resistance to PD‐(L)1 in Patients With Advanced/Metastatic Non‐Small Cell Lung Cancer
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: Yalun Li
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine State Key Laboratory of Respiratory Health and Multimorbidity Precision Medicine Key Laboratory of Sichuan Province West China Hospital Sichuan University  Chengdu China
Lung Cancer Center/Lung Cancer Institute West China Hospital Sichuan University Chengdu China
Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, China
Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China
raw_author_name: Jin Zhou
raw_affiliation_strings: Department of Medical Oncology Sichuan Clinical Research Center for Cancer Sichuan Cancer Hospital &amp; Institute Sichuan Cancer Center Affiliated Cancer Hospital of University of Electronic Science and Technology Chengdu China
Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology, Chengdu, China
raw_author_name: Li Jiang
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine Affiliated Hospital of North Sichuan Medical College  Nanchong China
Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, China
raw_author_name: Hua Xie
raw_affiliation_strings: Department of Medical Oncology Sichuan Clinical Research Center for Cancer Sichuan Cancer Hospital &amp; Institute Sichuan Cancer Center Affiliated Cancer Hospital of University of Electronic Science and Technology Chengdu China
Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology, Chengdu, China
raw_author_name: Zonglian Gong
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine Affiliated Hospital of North Sichuan Medical College  Nanchong China
Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, China
raw_author_name: Ke Wang
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine State Key Laboratory of Respiratory Health and Multimorbidity Precision Medicine Key Laboratory of Sichuan Province West China Hospital Sichuan University  Chengdu China
Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China
raw_author_name: Yan Zhang
raw_affiliation_strings: Lung Cancer Center/Lung Cancer Institute West China Hospital Sichuan University Chengdu China
Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, China
raw_author_name: Yan Li
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine State Key Laboratory of Respiratory Health and Multimorbidity Precision Medicine Key Laboratory of Sichuan Province West China Hospital Sichuan University  Chengdu China
Lung Cancer Center/Lung Cancer Institute West China Hospital Sichuan University Chengdu China
Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, China
raw_author_name: Weimin Li
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine State Key Laboratory of Respiratory Health and Multimorbidity Precision Medicine Key Laboratory of Sichuan Province West China Hospital Sichuan University  Chengdu China
Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China
raw_author_name: Panwen Tian
raw_affiliation_strings: Department of Pulmonary and Critical Care Medicine State Key Laboratory of Respiratory Health and Multimorbidity Precision Medicine Key Laboratory of Sichuan Province West China Hospital Sichuan University  Chengdu China
Lung Cancer Center/Lung Cancer Institute West China Hospital Sichuan University Chengdu China
Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, China
Department of Pulmonary and Critical Care Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, Precision Medicine Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu, China